KONINKLIJKE PHILIPS NV (PHG) research
KONINKLIJKE PHILIPS NV- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $23.92
- As of
KONINKLIJKE PHILIPS NV (PHG): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-07-28.
As of . Source: SEC EDGAR filings for PHG. Method and limitations.
Share the PHG intelligence card
See the full PHG dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for PHG on one page. Preview it with sample data, then open it live with a free account.
Preview the PHG dossierActive signals for PHG
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 97% of PHG (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +96% to PHG (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +129% to PHG (2026Q2)
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 36.7%, EPS $0.49 vs $0.3585 estimate
- mediumEARNINGS_BEAT
Q1-2026: Beat consensus by 12.2% - EPS $0.23 vs $0.205 estimate
FREE, NO ACCOUNT
Every signal on PHG, as it fires
You are seeing 5 of 8 signals recorded on PHG since 2026-05-30.
The five above landed across 3 days. The other 3 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in PHG (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLCCUSIP 500472303 · 2026Q2 | $4.2M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 500472303 · 2026Q2 | $2.4M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 500472303 · 2026Q2 | $454K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, PHG
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 20-FSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
PHG against its peers
PHG's operating margin of 8.0% ranks in the 80th percentile of 21 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-28 and 2026-05-31.
| Metric | PHG | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 17.8B EUR | n/a | n/a | 0 |
| Revenue YoY | -1.0% | n/a | n/a | 2 |
| Gross margin | 45.2% | 62.1% | 8 | 18 |
| Operating margin | 8.0% | -11.1% | 80 | 21 |
| Net margin | 5.0% | -9.4% | 70 | 21 |
| Return on equity | 8.2% | -10.6% | 70 | 21 |
| P / E | n/a | 28.9x | n/a | 6 |
Peers (21): SNN, BIO, GMED, NEOG, AXGN, BFLY, UFPT, ESTA, IART, AVNS, AORT, ENOV, BBNX, CBLL, SIBN, INMD, QDEL, SSII, KIDS, DCTH, MASS. Left out: ALMR (no annual filing), OSSUY (no annual filing), NHNKF (no annual filing), LMRI (no annual filing). Fiscal periods ending between 2025-12-28 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (PHG: 20-F), reported in EUR. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more PHG signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to PHGand get the insider, 13F, options, and confluence read in one view.